{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.1444.3.147","meta":{"versionId":"6","lastUpdated":"2021-03-06T01:00:18.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.147","version":"20210306","name":"Rolapitant Injectable","status":"active","date":"2021-03-06T01:00:18-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1986885","display":"92.5 ML rolapitant 1.8 MG/ML Injection"}]}]},"expansion":{"identifier":"urn:uuid:ed33e8c2-e08f-45ba-9076-bccdb9e6e73d","timestamp":"2022-06-10T11:42:57-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1986885","display":"92.5 ML rolapitant 1.8 MG/ML Injection"}]}}